Pharmacist Digest

What the noses of mice can tell us about the inheritance of trauma

STAT

APRIL 12, 2024

In the final year of World War II, Nazi troops starved the Netherlands in a brutal event known as the Dutch Hunger Winter. Some 20,000 people died and millions more suffered from this man-made famine.

Diabetes

What the brains of song birds can teach us about human stuttering

STAT

MARCH 15, 2024

A symphony of synapses fires every time a songbird sings. For Erich Jarvis, a neurobiologist at Rockefeller University, the neural pathways he finds particularly interesting inside a birds’ brain are those that enable the bird to make new sounds from listening to their environment.

Opinion: What ‘The Bear’ can teach us about hospitality in medicine

STAT

AUGUST 8, 2023

The FX/Hulu show “The Bear” transports viewers inside the tense world of restaurants.

Hospitals

What The NAPLEX 2022 Pass Rate Tells Us About 2023

Med Ed 101

FEBRUARY 26, 2023

Just looking at the California Board of Pharmacy […] The post What The NAPLEX 2022 Pass Rate Tells Us About 2023 appeared first on Med Ed 101. The pass rate that year was an indicator that the NAPLEX was not very difficult. That is not the case anymore.

Opinion: What the hospital-at-home movement tells us about igniting innovation in health care

STAT

AUGUST 21, 2023

As a health care economist who studies innovation, and as a management consultant who helps health systems and insurers adopt new technologies, we have had a ringside seat to a frustrating phenomenon: The large private sector of the U.S.

Hospitals

STAT+: What the Covid-19 pandemic can teach us about drug patents

STAT

MAY 3, 2023

Inventing treatments and vaccines is only part of the battle in an epidemic and pandemic, according to Priti Krishtel, the co-founder of the Initiative for Medicines, Access, and Knowledge (I-MAK). Once invented, we must find a way to get those products to everyone.

Vaccines

What the dogs of Chernobyl can teach us about life at the edge

STAT

MARCH 3, 2023

You’d think an irradiated wasteland would be a poor place to make a home, but some animals beg to differ.

STAT+: What past blockbusters can tell us about future of Wegovy and other weight loss medicines

STAT

AUGUST 24, 2023

The news that the weight loss drug Wegovy reduced the risk of heart attacks and strokes in overweight volunteers opens up the door to vastly expanded use of the drug and medicines like it, known as GLP-1 inhibitors.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

Tell us about your experience with telehealth linked to pharma companies

STAT

SEPTEMBER 14, 2022

When a patient sees an ad or visits a manufacturer’s website today, many will find buttons to “talk to a doctor now” about their symptoms.

In armadillos, leprosy expands healthy liver tissue. Could that tell us something about regenerating our own?

STAT

NOVEMBER 17, 2022

The mystery started with some skin samples. Anura Rambukkana was a Ph.D. student in Amsterdam, analyzing biopsies from migrants with Hansen’s disease, or leprosy. The illness could be painful and disfiguring, but in the lab, the infected cells didn’t look sickly. To Rambukkana’s eye, they seemed to be doing great.

Opinion: What the recent failures of Mindstrong and Pear tell us about the future of digital mental health

STAT

APRIL 18, 2023

Over the past five years, digital mental health has risen from a niche topic to a global health priority. Patients, researchers, regulators, and investors alike are thrilled by the potential of ubiquitous mobile technology like smartphones to help diagnose problems, monitor health, and even deliver evidence-based therapies.

What US trial sponsors should know about the GDPR

BioPharma Dive

JULY 3, 2023

What is the GDPR and why does it matter to your life sciences company. iliomad Health Data can help you maintain GDPR compliance.

Opinion: Lessons to psychiatrists-in-training from the CIA’s mind-control projects

STAT

APRIL 23, 2024

“Something you’re not telling us?” The jokes — about how I was secretly working for America’s international spy service — wrote themselves. My chief resident gave me a strange look when I arrived for another day of work at the Mayo Clinic one morning. I laughed along.

Mayo Clinic

Listen: AI in medicine, detangling hype, and Icelandic DNA

STAT

FEBRUARY 8, 2024

What can machines teach us about medicine? First, STAT’s Casey Ross joins us to explain his reporting on how researchers and pharmaceutical firms are using the technology to find new drug targets, design therapies, and improve clinical trials. Has AI really solved biology? And what’s a digital twin?

Opinion: People like me with bipolar disorder must help shape research and clinical care

STAT

MAY 3, 2024

Known throughout history by many names, like depression, mania, manic-depressive illness, or psychosis, the disorder is common and closely tied to that which makes us human: our thinking, our behavior, our hopes, and our ambitions.

STAT+: Patient advocates clash over wisdom of ‘approving drugs faster and faster’

STAT

MARCH 25, 2024

“We’re approving drugs faster and faster — [the FDA is] one of the fastest regulatory agencies in the world — we know less and less about them, and we pay more and more for them,” said Gonsalves, now a professor at Yale, at STAT Breakthrough Summit East on Thursday.

STAT Virtual Event | Navigating a New Era in Alzheimer’s Treatment

STAT

MAY 7, 2024

Join us for a conversation with a practicing neurologist, neuroscientist and geriatrician about overcoming current hurdles involved in diagnosing, treating, and monitoring patients in a new era for Alzheimer’s disease.

STAT+: Amylyx ALS drug failure leaves patients, advocates, and researchers reeling — and wondering what’s next

STAT

MARCH 8, 2024

Amylyx Pharmaceuticals’ announcement Friday that its drug, marketed as Relyvrio, failed to beat placebo in a pivotal study marks “a sad day for us, but we have to believe the data,” said Mary Catherine Collet, an ALS advocate. Continue to STAT+ to read the full story…

Drug Development

Rats have an imagination, too, researchers show with brain implants

STAT

NOVEMBER 2, 2023

Our minds have a weird and wondrous way of transporting us to other places and times. You might find yourself, for instance, immersed in the vivid world of a novel, or reminiscing about a potluck with close friends. These reveries can feel magical, but they’re the result of complex electric signals zipping through the brain.

How resurrecting extinct species might impact medicine

STAT

APRIL 4, 2024

Today, we see how the GLP-1s might be harnessed for Parkinson’s, we learn about species de-extinction efforts, and BIO’s CEO tells us why the U.S. Sign up to get our biotech newsletter in your inbox. Hey, it’s Meghana. needs to stay on top in biotech. Read the rest…

Drug Pricing

Drug Pricing Drug Development

Opinion: How headlines about the RSV antibody injection could cloud parents’ decision-making

STAT

OCTOBER 3, 2023

As theorists from Samuel Coleridge to Kenneth Burke have noted, language often does our thinking for us. In health care, all too often, that leads to problems. Read the rest…

STAT+: Pharmalittle: We’re reading about slow uptake of an Alzheimer’s drug, an opioid lawsuit, and more

STAT

FEBRUARY 14, 2024

We are doing just fine, thank you, especially since the middle of the week is upon us. Meanwhile, you might want to mark your calendar for an upcoming chat about biosimilars. About 3,800 patients with early-stage Alzheimer’s have signed up on multiple registries to receive the drug, called Leqembi, as of last month, he added.

Biosimilars

Women spend 20% more per year on out-of-pocket health costs, says report

STAT

SEPTEMBER 29, 2023

In 2021, that meant that women paid about 20% more than men — only 2% of which could be accounted for by maternity care. Women of all ages pay a total of $15.4 billion more than men on annual out-of-pocket medical expenses, according to a new report from Deloitte. chief health equity officer.

Experts talk detecting disease from voice biomarkers with AI, privacy concerns

STAT

NOVEMBER 7, 2023

Over the past few years, researchers have started using AI to capture signals from our voices in hopes of quickly diagnosing diseases. Academics and startup founders in the nascent field talked about the potential benefits, as well as the privacy implications, of this technology at the Milken Institute Future of Health Summit on Tuesday.

Opinion: Listen: Why long Covid might predate the pandemic

STAT

OCTOBER 18, 2023

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. But what if long Covid isn’t the right way to think about what they are going through? But what if long Covid isn’t the right way to think about what they are going through?

STAT+: Novo’s Catalent deal is great for GLP-1s. But what about drug manufacturing?

STAT

FEBRUARY 5, 2024

The deal, done in part so that Novo can rapidly ramp up its ability to manufacture Wegovy, is a massive statement of optimism about the sales potential of that medication and weight loss drugs like it, known as GLP-1s.

Vaccines

Opinion: How to make after-hours primary care better for doctors — and patients

STAT

FEBRUARY 22, 2024

One of us, Jeffrey M., It is midafternoon, and a patient leaves a message with our answering service — she is concerned about her mother’s respiratory symptoms. is on weekend call for our office-based internal medicine practice. So, Jeffrey interrupts his late lunch and rings her back.

Hospitals

STAT+: A ‘vaccine-like’ version of Wegovy is on the drawing board at Novo Nordisk

STAT

FEBRUARY 29, 2024

“We have a very early think tank on: what would it take us, from a technology point of view and from an ecosystem point of view, to make long-lasting GLP-1 molecules?” ” Marcus Schindler, Novo’s chief scientific officer, said in an interview with STAT Wednesday.

Vaccines

STAT+: Pharmalittle: We’re reading about Takeda restructuring, Pfizer settling Zantac suits, and more

STAT

MAY 9, 2024

As for us, we are engaged in the usual ritual of brewing cups of stimulation. As always, you are invited to join us. Last month, Sanofi agreed to pay more than $100 million to resolve about 4,000 cases. Our choice today is orange cream. The agreements cover cases in state courts across the U.S.

Opinion: Looking for a climate job? Consider biotech

STAT

SEPTEMBER 5, 2023

But when we think about climate work, we tend to imagine only a small number of activities, like integrating renewables into the grid or planning cities to be resilient against flooding and fires. That makes sense, since the vast majority of biotech products we hear about are drugs, like mRNA vaccines, gene therapies, or insulin.

Vaccines

Looking Back to Go Forward: What 2023 Has Taught Us About Biosimilar Adoption

Pharmacy Times

JANUARY 19, 2024

In 2024, there is an urgent need for policies that will accelerate biosimilar use to achieve lower system-wide health care costs.

Biosimilars

Opinion: Personalized medicine: We’re not there yet

STAT

APRIL 5, 2024

When Francis Collins, then-director of the National Human Genome Research Institute, testified before Congress in 2003 about the significance of sequencing the human genome that year, he introduced personalized medicine as a new concept.

Diabetes

STAT+: White House to hold a listening session on reforming pharmacy benefit managers

STAT

FEBRUARY 28, 2024

He will “just convey what our experience has been at Cost Plus and, if they ask, [make] suggestions on what we think can make things better,” he told us when asked about his expectations for the meeting. Continue to STAT+ to read the full story…

BridgeBio’s big week, Lilly’s Alzheimer’s data, & succession at Stanford

STAT

JULY 20, 2023

What can Homer teach us about biotech? Neil Kumar, CEO of BridgeBio, joins us to talk about how his small company came to develop what could be a big drug — and why classical Greek literature remains relevant. Has Big Science gotten too big? And what’s the future of treating Alzheimer’s disease?

STAT+: Equity, technology, and costs top of mind for life science’s leaders

STAT

APRIL 24, 2024

Members of this year’s list (and a few past honorees) spoke about what issues in their fields — ranging from investment to clinical research to bedside treatment — need to be prioritized in order to improve health care across the U.S. and the rest of the world.

Medical Schools

Medical Schools Hospitals

STAT+: Thermo Fisher just opened a $180 million plant. Executives already are talking about expanding.

STAT

SEPTEMBER 21, 2023

Thermo Fisher Scientific’s giant plant to manufacture gene therapies for drug companies is barely a year old, but executives at the maker of scientific tools are already talking about expanding. So far, the company is only using about 290,000 of the plant’s more than 400,000 square feet.

Opinion: Four communication lessons we learned the hard way during the pandemic

STAT

JUNE 6, 2023

Now that the Covid-19 public health emergency has ended, it’s awfully tempting to put the pandemic firmly behind us. One thing that we haven’t talked about enough is the victories. Read the rest…

Communication

STAT+: Mount Sinai’s responses to STAT’s questions about the Living Brain Project

STAT

MAY 1, 2024

Can you describe for us what the Living Brain Project has accomplished, to date, and what promise the investigators feel it holds for future brain research? As part of its reporting on Mount Sinai and the Living Brain Project, STAT sent a list of written questions to Mount Sinai. Below is a copy of the questions and responses.

Hospitals

What Can One Life Tell Us About the Battle Against H.I.V.?

NY Times

DECEMBER 2, 2021

In 2001, U.N. estimates suggested 150 million people would be infected with H.I.V. That preceded an ambitious global campaign to curb the virus. How well did it work?

Immunity

Immunity Immunization

With increased virus activity, providers urged to be alert for signs of rare polio-like syndrome in kids

STAT

SEPTEMBER 12, 2022

Pediatricians and top health officials are warning about an uptick in activity of a common virus that in rare cases can cause a polio-like syndrome in young children. The virus, an enterovirus known as EV-D68, is one of the bugs that regularly circulates and infects us from time to time, typically just causing colds.

The ‘Hispanic Paradox’ intrigues a new generation of researchers determined to unravel it

STAT

SEPTEMBER 14, 2023

They are also looking at what the survival edge can teach us about further improving the health of Hispanics, who make up nearly one-fifth of the U.S. population, and improving health for the rest of the country as well. Read the rest…

Diabetes

European Generic Medication Shortages Raise Concerns About US Drug Supply

Pharmacy Times

JANUARY 17, 2023

Energy crisis in Europe puts strain on production and could have ramifications that extend beyond the continent's borders.

Opinion: Psychiatrists like us cannot keep up with their inboxes

STAT

AUGUST 28, 2023

But if you’re working in a clinic setting (like one of us, Jessi, is currently, and the other, Simone, has done previously), one thing is for sure: You’re busy. And it’s not just about seeing patients — it’s the seemingly ever-increasing electronic messages. Read the rest…

STAT+: FDA cracks down on websites that claim to sell chemicals in obesity drugs Wegovy, Zepbound

STAT

FEBRUARY 15, 2024

DBA Helix Chemical Supply and US Chem Labs.

Diabetes

What the noses of mice can tell us about the inheritance of trauma

What the brains of song birds can teach us about human stuttering

Trending Sources

Opinion: What ‘The Bear’ can teach us about hospitality in medicine

What The NAPLEX 2022 Pass Rate Tells Us About 2023

Opinion: What the hospital-at-home movement tells us about igniting innovation in health care

STAT+: What the Covid-19 pandemic can teach us about drug patents

What the dogs of Chernobyl can teach us about life at the edge

STAT+: What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Tell us about your experience with telehealth linked to pharma companies

In armadillos, leprosy expands healthy liver tissue. Could that tell us something about regenerating our own?

Opinion: What the recent failures of Mindstrong and Pear tell us about the future of digital mental health

What US trial sponsors should know about the GDPR

Opinion: Lessons to psychiatrists-in-training from the CIA’s mind-control projects

Listen: AI in medicine, detangling hype, and Icelandic DNA

Opinion: People like me with bipolar disorder must help shape research and clinical care

STAT+: Patient advocates clash over wisdom of ‘approving drugs faster and faster’

STAT Virtual Event | Navigating a New Era in Alzheimer’s Treatment

STAT+: Amylyx ALS drug failure leaves patients, advocates, and researchers reeling — and wondering what’s next

Rats have an imagination, too, researchers show with brain implants

How resurrecting extinct species might impact medicine

Opinion: How headlines about the RSV antibody injection could cloud parents’ decision-making

STAT+: Pharmalittle: We’re reading about slow uptake of an Alzheimer’s drug, an opioid lawsuit, and more

Women spend 20% more per year on out-of-pocket health costs, says report

Experts talk detecting disease from voice biomarkers with AI, privacy concerns

Opinion: Listen: Why long Covid might predate the pandemic

STAT+: Novo’s Catalent deal is great for GLP-1s. But what about drug manufacturing?

Opinion: How to make after-hours primary care better for doctors — and patients

STAT+: A ‘vaccine-like’ version of Wegovy is on the drawing board at Novo Nordisk

STAT+: Pharmalittle: We’re reading about Takeda restructuring, Pfizer settling Zantac suits, and more

Opinion: Looking for a climate job? Consider biotech

Looking Back to Go Forward: What 2023 Has Taught Us About Biosimilar Adoption

Opinion: Personalized medicine: We’re not there yet

STAT+: White House to hold a listening session on reforming pharmacy benefit managers

BridgeBio’s big week, Lilly’s Alzheimer’s data, & succession at Stanford

STAT+: Equity, technology, and costs top of mind for life science’s leaders

STAT+: Thermo Fisher just opened a $180 million plant. Executives already are talking about expanding.

Opinion: Four communication lessons we learned the hard way during the pandemic

STAT+: Mount Sinai’s responses to STAT’s questions about the Living Brain Project

What Can One Life Tell Us About the Battle Against H.I.V.?

With increased virus activity, providers urged to be alert for signs of rare polio-like syndrome in kids

The ‘Hispanic Paradox’ intrigues a new generation of researchers determined to unravel it

European Generic Medication Shortages Raise Concerns About US Drug Supply

Opinion: Psychiatrists like us cannot keep up with their inboxes

STAT+: FDA cracks down on websites that claim to sell chemicals in obesity drugs Wegovy, Zepbound

Stay Connected